261 related articles for article (PubMed ID: 28512178)
1. Particulate Generation Mechanisms during Bulk Filling and Mitigation via New Glass Vial.
Timmons CL; Liu CY; Merkle S
PDA J Pharm Sci Technol; 2017; 71(5):379-392. PubMed ID: 28512178
[TBL] [Abstract][Full Text] [Related]
2. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
[TBL] [Abstract][Full Text] [Related]
3. Particulate Study on NeoProfen, a Neonatal Injectable Product.
Krishna A; Rice M; Kester T; Waters M; Wilson T
PDA J Pharm Sci Technol; 2016; 70(1):76-92. PubMed ID: 26889056
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Patient Safety through the Use of a Pharmaceutical Glass Designed To Prevent Cracked Containers.
Schaut RA; Hoff KC; Demartino SE; Denson WK; Verkleeren RL
PDA J Pharm Sci Technol; 2017; 71(6):511-528. PubMed ID: 28928290
[TBL] [Abstract][Full Text] [Related]
5. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M
PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443
[TBL] [Abstract][Full Text] [Related]
6. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
Hladik B; Buscke F; Frost R; Rothhaar U
PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
[TBL] [Abstract][Full Text] [Related]
7. Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations.
Anger S; Begat C; Crnko V; Fantozzi G; Farach W; Fitzpatrick S; Gallagher B; Huelsmann S; Kinsey P; Langlade V; Lefevre G; Legendre E; McLean K; Miller J; Patel R; Perry A; Soukiassian H; Stanton A; Streich D; Timmons C; Vaneylen D; van Hoose T; Wildling L; Windover M
PDA J Pharm Sci Technol; 2019; 73(6):635-647. PubMed ID: 31420504
[TBL] [Abstract][Full Text] [Related]
8. Investigating factors leading to fogging of glass vials in lyophilized drug products.
Abdul-Fattah AM; Oeschger R; Roehl H; Bauer Dauphin I; Worgull M; Kallmeyer G; Mahler HC
Eur J Pharm Biopharm; 2013 Oct; 85(2):314-26. PubMed ID: 23791681
[TBL] [Abstract][Full Text] [Related]
9. Characterization of surface properties of glass vials used as primary packaging material for parenterals.
Ditter D; Mahler HC; Roehl H; Wahl M; Huwyler J; Nieto A; Allmendinger A
Eur J Pharm Biopharm; 2018 Apr; 125():58-67. PubMed ID: 29331438
[TBL] [Abstract][Full Text] [Related]
10. Risk Mitigation of Drug Shortages-A New Concept for Vials Designed to Improve Fill and Finish Performance.
Roehl H; Mangold S; Maurer F; Loeber D
PDA J Pharm Sci Technol; 2021; 75(2):141-156. PubMed ID: 32999076
[TBL] [Abstract][Full Text] [Related]
11. Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity.
Ovadia R; Streubel A; Webb-Vargas Y; Ulland L; Luemkemann J; Rauch K; Eder J; Lam P; Tegoulia V; Maa YF
PDA J Pharm Sci Technol; 2019; 73(1):2-15. PubMed ID: 29954924
[TBL] [Abstract][Full Text] [Related]
12. Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials.
Nashed-Samuel Y; Gastwirt J; Kotia RB; Moore S; Masatani P; Torraca G; Goss M; Dolan DG; Akers M; Padala C; Wypych J; Semin DJ
J Pharm Sci; 2022 Dec; 111(12):3275-3286. PubMed ID: 36116524
[TBL] [Abstract][Full Text] [Related]
13. Residual Seal Force Testing: A Suitable Method for Seal Quality Determination of (High Potent) Parenterals.
Buecheler JW; Luemkemann J; Gieseler H; Mohl S; Streubel A
PDA J Pharm Sci Technol; 2019; 73(2):111-120. PubMed ID: 30361287
[TBL] [Abstract][Full Text] [Related]
14. Determining the delamination propensity of pharmaceutical glass vials using a direct stress method.
Sloey C; Gleason C; Phillips J
PDA J Pharm Sci Technol; 2013; 67(1):35-42. PubMed ID: 23385562
[TBL] [Abstract][Full Text] [Related]
15. A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application.
Lee KR; Chae YJ; Cho SE; Chung SJ
Drug Dev Ind Pharm; 2011 Dec; 37(12):1394-401. PubMed ID: 21702739
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Acid Titration, Conductivity, Flame Photometry, ICP-MS, and Accelerated Lamellae Formation Techniques in Determining Glass Vial Quality.
Fujimori K; Lee H; Sloey C; Ricci MS; Wen ZQ; Phillips J; Nashed-Samuel Y
PDA J Pharm Sci Technol; 2016; 70(3):248-55. PubMed ID: 27091889
[TBL] [Abstract][Full Text] [Related]
17. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.
Guadagnino E; Zuccato D
PDA J Pharm Sci Technol; 2012; 66(2):116-25. PubMed ID: 22492597
[TBL] [Abstract][Full Text] [Related]
18. Freeze Drying and Vial Breakage: Misconceptions, Root Causes and Mitigation Strategies for the Pharmaceutical Industry.
Jin X; O'Grady D; Affleck RP; Martini S; Saluja A
J Pharm Sci; 2024 May; 113(5):1306-1318. PubMed ID: 38103690
[TBL] [Abstract][Full Text] [Related]
19. A method to quantitatively define and assess the risk of cosmetic glass defects on tubing glass vials.
Loui AW
PDA J Pharm Sci Technol; 2011; 65(4):380-91. PubMed ID: 22293525
[TBL] [Abstract][Full Text] [Related]
20. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
